Is Victoza FDA Approved?
DrugStatusIndex provides a clear, data-driven view of the regulatory status of medications, compounds, and related products. This page explains whether Victoza is FDA approved and how it is commonly categorized.
Overview
Victoza is the brand name for liraglutide, a once-daily injectable GLP-1 receptor agonist used to improve blood sugar control in adults and children with type 2 diabetes.
FDA Status Details
Victoza is classified as FDA Approved. It was approved by the FDA for type 2 diabetes management and to reduce the risk of major cardiovascular events in qualifying adults.
Approved Use
Victoza is approved for glycemic control in type 2 diabetes and cardiovascular risk reduction. It is not FDA approved specifically for chronic weight management like Saxenda, even though both contain liraglutide.
Prescription Status
Victoza is an FDA-approved branded prescription medication and should be distinguished from compounded liraglutide products or non-approved peptide offerings sold online.
Search Another Drug or Compound
Use DrugStatusIndex to review public regulatory status information for medications, compounds, and related products.